Monitor for signs and symptoms of volume depletion, and renal function after initiating therapy
Specifically, HIF-1 exerts a crucial influence on synovial inflammation, angiogenesis, and regulation of cellular metabolism in RA, among other processes
The supplement industry has witnessed a seismic shift in recent months, as mainstream attention turns toward GLP-1 receptor agonists like semaglutide for their remarkable effects on blood sugar control and body composition
There are four GLP-1 FDA decisions to watch in 2026 Eli Lillys injectable Mounjaro, with a new indication to reduce the risk of major adverse cardiovascular events in patients with T2DM, is expected in mid-2026
Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study